This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n9http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q69916231
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована у квітні 1988 scientific article published on 01 April 1988 im April 1988 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'abril de 1988 wetenschappelijk artikel article scientifique publié en 1988
p:P577
wds:Q69916231-1E605599-77A2-4E71-90E4-79D29381208E
wdt:P577
1988-04-01T00:00:00Z
p:P407
wds:Q69916231-B9FEC1F1-D632-4553-8091-00EE2EF68184
wdt:P407
wd:Q1860
rdfs:label
A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group
skos:prefLabel
A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group
schema:name
A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group
p:P1476
wds:Q69916231-46B51F6D-2BDD-432F-AC7C-80A85E4239C8
wdt:P1476
A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group
p:P304
wds:Q69916231-A60D0016-2CF7-4C1B-921E-F1C604598818
wdt:P304
679-688
p:P31
wds:Q69916231-CBE568F6-3C51-44F0-A88D-F4745C8F2906
wdt:P31
wd:Q13442814
p:P921
wds:Q69916231-1858DAF1-5C74-4FC9-A995-C45C5450B932 wds:Q69916231-F6695FFE-F79B-48DF-A016-BC5B5AB2889E wds:Q69916231-9189AB27-BF2D-45F7-B229-1B38F89DB3C1 wds:Q69916231-B6EBC1C0-1338-4300-816E-189DE940BEF4
wdt:P921
wd:Q42824827 wd:Q974135 wd:Q18936 wd:Q238512
p:P698
wds:Q69916231-FD315FED-6555-4464-AF09-E0CE076C1094
wdtn:P698
n12:2895801
wdt:P698
2895801
p:P1433
wds:Q69916231-04BD66D5-2220-4FE7-8DBB-FD053F5C46AF
wdt:P1433
wd:Q400292
p:P433
wds:Q69916231-2ADBC9BC-B746-40BB-BEDC-4C1713579A06
p:P478
wds:Q69916231-5DED87FB-8543-4E8E-A4E5-08DE0F4C5D47
wdt:P433
4
wdt:P478
6
p:P356
wds:Q69916231-44B3EDCC-4D98-4948-B3FD-A205F64475F5
wdtn:P356
n9:JCO.1988.6.4.679
wdt:P356
10.1200/JCO.1988.6.4.679